Novel indole containing thiazolidinedione derivatives as potent euglycemic and hypolipidaemic agents

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 7, 1997, Pages 785-788

  Lohray, Braj B ^a   Bhushan, V ^a   Rao, P Bheema ^a   Madhavan, G R ^a   Murali, N ^a   Rao, K Narasimha ^a   Reddy, K Anantha ^a   Rajesh, B M ^a   Reddy, P Ganpathy ^a   Chakrabarti, R ^a   Rajagopalan, R ^a  

^a DR REDDY S RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; INDOLE DERIVATIVE; THIAZOLIDINE DERIVATIVE; TRIACYLGLYCEROL; TROGLITAZONE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SYNTHESIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IN VITRO STUDY; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; OBESITY; ORAL DRUG ADMINISTRATION;

EID: 0030898472     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00118-2     Document Type: Article

References (31)

1. Turner, N.C. Drug Discovery Today 1996, 1 (3) 109-116.
2. Gavin, J. R. Am. J. Med. 1985, 79 (Suppl. 3B), 34-42.
3. (a) Steiner, K.E.; Lien, E. L. Prog. Med. Chem. 1987, 24, 209.
4. (b) Larson, E. R.; Clark, D.A.; Stevenson, R. W. Annu. Rep. Med. Chem. 1990, 25, 205.
5. (c) Colca, J. R.; Tanis, S. P. Annu. Rep. Med. Chem. 1992, 27, 219.
6. (a) Fujita, T.; Sugiyama, Y.; Taketomi, S.; Sohda, T. Diabetes 1983, 32, 804
7. (b) Chang, A. Y.; Wyse, B. M. Gilchrist, B. J.; Peterson, T.; Diani, A. R.; Diabetes 1983, 32, 830.
8. Sohda, T.; Mizuno, K.; Tawada, H.; Imamiya, E.; Sugiyama, Y.; Fujita, T.; Kawamatsu, Y. Chem. Pharm. Bull. 1982, 36, 3563 and 3580.
9. (a) Clark, D. A.; Goldstein, S. W.; Volkmann, R. A.; Eggler, J. F.; Holland, G. F.; Hulin, B.; Stevenson, R. W.; Kreutter, D. K.; Gibbs, E. M.; Krupp, M. N. Merrigan, P.; Kelbaugh, P. L.; Andrews, GE. G.; Tickner, D. L.; Suleske, R. T.; Lamphere, C. H.; Rajeckas, F. J.; Kappeler, W. H.; McDermott, R. E.; Hutson, N. J.; Johnson, M. R. J. Med. Chem. 1991, 34, 319.
10. (b) Dow, R. L.; Bechle, B. M.; Chou, T. T.; Clark, D. A.; Hulin, B.; Stevenson, R. W. J. Med. Chem. 1991, 34, 1538.
11. (c) Hulin, B.; Clark, D. A.; Goldstein, S. W.; McDermott, R. E.; Dambek, P. J.; Kappeler, W. H.; Lamphere, C. H.; Lewis, D. M.; Rizzi, J. P. J. Med. Chem. 1992, 35, 1853.
12. (d) Sohda, T.; Mizuno, K.; Mamose, Y.; Ikeda, H.; Fujita, T.; Meguro, K. J. Med. Chem. 1992, 35, 2617-2626.
13. (e) Cantello, B. C. C.; Cawthorne, M. A.; Cottam, G. P.; Duff, P. T.; Haigh, D.; Hindley, R. M.; Lister, C. A.; Smith, S. A.; Thurlby, P. L. J. Med. Chem. 1994, 37, 3977.
14. (a) Williams, D. G.; Deldar, A.; Jordan, W. H.; Gries, C.; Long, G. G.; Dimarchi, R.D. Diabetes 1993, 42, (suppl. 1), 59 A (abstr. 186).
15. (b) Deldar, A.; William, G.; Stevenes, C. Diabetes 1993, 42 (suppl. 1) 57A (abstr. 179).
16. Hulin, B.; McCarthy, P. A.; Gibbs, E. M. Curr. Pharm. Design 1996, 2, 85-102.
17. Troglitazone is expected to reach Japanese market by April, 1997.
18. (a) Kees, K. L.; Smith, T. M.; McCaleb, M. L.; Prozialeck, D. H.; Cheeseman, R. S.; Christos, T. E.; Patt, W. C.; Steiner, K. E.; J. Med. Chem. 1992, 35, 944.
19. (b) Ellingboe, J. W.; Alessi, T. R.; Dolak, T. M.; Nguyen, T. T.; Tomer, J. D.; Guzzo, F.; Bagli, J. F.; McCaleb, M. L. J. Med. Chem. 1992, 35, 1176.
20. (c) Goldstein, S. W.; McDermott, R. E.; Gibbs, E. M.; Stevensen, R. W.; J. Med. Chem. 1993, 36, 2238.
21. (d) Ellingboe, J. W.; Lombardo, L. J.; Alessi, T. R.; Nguyen, T. T.; Guzzo, F.; Guinosso, C. J.; Bullington, J.; Browne, E. N. C.; Bagli, J. F.; Wrenn, J.; Steiner, K.; McCaleb, M. L. J. Med. Chem. 1993, 36, 2485.
22. (e) Kees, K. L.; Caggiano, T. J.; Steiner, K. E.; Fitzgerald, Jr. J. J.; Kates, M. J.; Christos, T. E.; Kulishoff, Jr. J. M.; Moore, R. D.; McCaleb, M. L. J. Med. Chem. 1995, 38, 617.
23. (f) Buckle, D. R.; Cantello, B. C. C.; Cawthorne, M. A.; Coyle, P. J.; Dean, D. K.; Faller, A.; Haigh, D.; Hindley, R. M.; Jefcott, L. J.; Lister, C. A.; Pinto, I. L.; Rami, H. K.; Smith, D. G.; Smith, S. A. Bioorg. Med. Chem. Lett. 1996, 6, 2121.
24. (g) Buckle, D. R.; Cantello, B. C. C.; Cawthorne, M. A.; Coyle, P. J.; Dean, D. K.; Faller, A.; Haigh, D.; Hindley, R. M.; Jefcott, L. J.; Lister, C. A.; Pinto, I. L.; Rami, H. K.; Smith, D. G.; Smith, S. A. Bioorg. Med. Chem. Lett. 1996, 6, 2127.
25. (h) Hulin, B.; Newton, L. S.; Lewis, D. M.; Genereux, P. E.; Gibbs, M.; Clark, D. A. J. Med. Chem. 1996, 39, 3897.
26. (i) Kees, K. L.; Fitzgerald, Jr. J. J.; Steiner, K. E.; Mattes, J. F.; Mihan, B.; Tosi, T.; Mondoro, D.; McCaleb, M. L. J. Med. Chem. 1996, 39, 3920.
27. Youngdale, G. A.; Sih, J. C.; Tanis, S. P. Lin, C. -H., WO 90, 05721, Chem. Abstr. 1990, 113, 211831m.
28. A patent application describing substituted indols has appeared recently, Fujita, T. et.al. EP 676, 398 (1995), Chem. Abstr. 1996, 124, 87002c.
29. A patent application describing substituted indols has appeared recently, Fujita, T. et.al. EP 676, 398 (1995), Chem. Abstr. 1996, 124, 87002c.
30. MacLeod, A. M.; Cascieri, M. A.; Merchant, K. J.; Sodawski, S.; Hardwick, S.; Lewis, R. T.; MacIntyre, D. E.; Metzger, J. M.; Fong, T. M.; Shepheard, S.; Tattersall, F. D.; Hargreaves, R.; Baker, R. J. Med. Chem. 1995, 38, 934.
31. + = 366.